Irrigation of Bupivacaine at the Surgical Bed for Postoperative Pain Relief After Laparoscopic Cholecystectomy for Acute Cholecystitis
1 other identifier
interventional
64
1 country
1
Brief Summary
This study aims to compare the effectiveness of irrigation of 0.5% bupivacaine versus normal saline at the gallbladder surgical bed in reducing postoperative pain following laparoscopic cholecystectomy for acute cholecystitis. Postoperative pain remains a common concern despite the minimally invasive nature of laparoscopic surgery. The study evaluates pain intensity at 4, 8, and 12 hours after surgery using the Visual Analogue Scale (VAS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Oct 2025
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedFirst Submitted
Initial submission to the registry
September 25, 2026
CompletedFirst Posted
Study publicly available on registry
October 1, 2026
CompletedOctober 1, 2026
September 1, 2026
7 months
September 25, 2026
September 25, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative Pain Intensity at 12 Hours
Pain intensity measured on a 0-10 Visual Analogue Scale (VAS), where 0 means no pain and 10 means the worst imaginable pain. Lower scores indicate less pain.
12 hours after surgery
Secondary Outcomes (1)
Number of Participants With Adverse Effects
Up to 12 hours after surgery
Study Arms (2)
Normal Saline Irrigation Group
PLACEBO COMPARATORPatients received 20 mL of 0.9% normal saline irrigated over the gallbladder bed using the same technique and timing as the bupivacaine group. Postoperative analgesia was standardized with scheduled intravenous non-steroidal anti-inflammatory drugs, with weak opioids as rescue.
Bupivacaine Irrigation Group
EXPERIMENTALPatients received 20 mL of 0.5% bupivacaine irrigated over the gallbladder bed through the lateral-most port immediately after specimen retrieval, before desufflation and port closure. Postoperative analgesia was standardized with scheduled intravenous non-steroidal anti-inflammatory drugs, with weak opioids as rescue.
Interventions
20 mL of 0.5% bupivacaine irrigated over the gallbladder bed through the lateral-most port after specimen retrieval, before desufflation and port closure.
20 mL of 0.9% sodium chloride irrigated over the gallbladder bed using the same technique and timing as the bupivacaine group.
Eligibility Criteria
You may qualify if:
- Age 18 to 60 years
- Acute cholecystitis confirmed by clinical findings (epigastric pain, abdominal tenderness, positive Murphy sign), ultrasound or CT findings (gallbladder wall thickening, pericholecystic fluid), and raised total leucocyte count and C-reactive protein
- Planned for laparoscopic cholecystectomy
- American Society of Anesthesiologists (ASA) physical status I or II
- Presentation within one week of symptom onset
- Able to provide written informed consent
You may not qualify if:
- Known allergy to amide local anaesthetics
- Uncontrolled hypertension
- Documented psychiatric disorder
- Gallbladder empyema, mucocele, or perforation
- Conversion to open cholecystectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. Ziauddin Hospital
Karachi, Sindh, 75600, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
September 25, 2026
First Posted
October 1, 2026
Study Start
October 1, 2025
Primary Completion
April 30, 2026
Study Completion
April 30, 2026
Last Updated
October 1, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Starting after publication of the results and available for 5 years.
- Access Criteria
- Requests should be sent to the Principal Investigator with a brief research proposal. Data will be shared after approval by the investigators, subject to Ziauddin University Ethics Review Committee requirements.
De-identified individual participant data on the study outcomes (Visual Analogue Scale pain scores) and baseline characteristics will be shared on reasonable request.